Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2023 / Apr / InVision: A Clear View
Technology and innovation Research and Innovations

InVision: A Clear View

Increasing the yield of lymph nodes to save time, money, and lives

04/17/2023 1 min read

Sponsored By

Share

Locating and identifying lymph nodes within surgical specimens is a challenging, but vital part of pathology. A laboratory professional’s ability to correctly spot lymph nodes directly affects accurate cancer staging. Therefore, any innovation has tremendous implications on patient care. Unfortunately, in many cases, lymph node yield minimums established by the National Comprehensive Cancer Network (NCCN) are left unmet. This most commonly occurs in colorectal resections, specifically those treated with neoadjuvant therapy. When lymph node yield is compromised, patient care suffers. Studies have demonstrated that retrieval of higher numbers of lymph nodes is correlated with better patient outcomes. Therefore, there is great potential for yield improvement and, consequently, impact on patient care. 

A new revolutionary tool that’s leading the change for innovation is InVision – an optical imaging device that provides enhanced imaging contrast and assists laboratory professionals in finding lymph nodes. InVision allows clinicians to see lymph nodes like never before. This optical imaging device depicts lymph nodes in high contrast against surrounding adipose tissue – all in real time. There’s no need for injected dyes, fluorescent tags, or radiation.

InVision uses military-grade technology previously unavailable for public use that leverages the difference in water content between lymph nodes and adipose tissue. Infrared light sensing technology helps to enhance visual contrast, and boosts lymph node yield. InVision can be seamlessly integrated into existing anatomic pathology workflows thereby improving the efficiency and accuracy of cancer staging. 

InVision is a winner of the 2023 Red Dot Design Awards in the medical device and technology category. The success of this technology can be attributed to the pathologists, pathologists’ assistants, and other laboratory professionals who have been at the forefront of its development. The product was built following more than 800 clinician interviews, ten iterations of prototype testing, and valuable input from numerous leaders and innovators throughout the pathology community. This has resulted in a device that is well-tailored for the needs of pathologists and pathologists’ assistants. Not only does InVision provide time-saving and potentially life-saving benefits, but by reducing the need for excess adipose tissue submission, labs can significantly reduce costs. 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.